Chase Pharmaceuticals Corporation   Report issue

For profit Phase 2
Founded: Washington D.C. United States (2007)
Status: Acquired by Allergan PLC (2015) (2016) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2014
NCT02185053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CHASE LABS NJ